Antibody-based profiling of blood plasma proteins for lung cancer diagnostics and screening.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.07.2010 | - | $2.72M | - |
Mentions in press and media 1
| Date | Title | Description |
| 19.07.2010 | Biosystems International Closes €2.1M Financing Round | Biosystems International (BSI) SAS, an Evry, France-based biotechnology company specializing in the development of monoclonal antibody based diagnostics for cancer, has closed a €2.1m ($2.7m) financing round.
Following the discovery of nove... |
Reviews 0
